V
Velocity Clinical Research | Providence East Greenwich
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
RGT001-075
BOS-580
Bupropion Hydrochloride
NVX-Cov2373
Naltrexone Hydrochloride
Parent organization
This site is a part of Velocity Clinical Research
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 6 total trials
A randomized, double-blinded, placebo controlled study intended to capture cardiovascular outcomes during real-world use of naltrexone/bupropion (NB).
Enrolling
Obesity
Drug: Placebo
Drug: Naltrexone-Bupropion (NB) Combination
This is a phase 2, 36-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the safety, tolerability, weight loss...
Active, not recruiting
Obesity or Overweight
Drug: Placebo Comparator
Drug: RGT001-075
Trial sponsors
R
C
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems